Antennova Marks Milestone in Cancer Treatment with Promising Early Results from Anti-CD24 Antibody Trial - MyChesCo
DOYLESTOWN, PA — In a significant stride toward advancing cancer treatment, Antennova, a clinical-stage biotechnology firm dedicated to oncology, has announced the successful completion of the first dosing cohort in …
Timothy Alexander
